El Segundo, CA – According to filings with the U.S. Securities and Exchange Commission, Biogix Inc. is raising $2,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Roman Trunin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biogix Inc.

Biogix is a science-driven company that develops, tests, manufactures, and distributes innovative products based on the unique platform of natural metabolites. Since its inception in 2006, the year when Biogix acquired the rights to its flagship product Amberen, the company has been supporting the clinical and scientific research and development of its formulation.

To learn more about Biogix Inc., visit http://amberen.com/

Contact:
Roman Trunin, Chief Executive Officer
310-568-1048
https://www.linkedin.com/in/romantrunin/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved